G Bradley Cole
CIK 1337798 · General Manager - Diagnostics · last filed 2026-07-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.92M
Companies
4
Total Filings
156
Lifetime Open-Market Net
-$33.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNSA | Director | 11,672 | $77.83 | $908.4K | -$299.1K | 9 | 2026-07-31 |
| CSTL | Director | 32,976 | $30.55 | $1.01M | -$210.7K | 12 | 2026-06-01 |
| EXACT SCIENCES CORP (EXAS) Delisted | General Manager - Diagnostics | 49,884 | $104.91 | $5.23M | -$5.89M | 4 | 2020-02-21 |
| GENOMIC HEALTH INC (GHDX) Delisted | CFO | 84,342 | — | — | -$27.34M | 128 | 2019-10-09 |
Recent Filings · Page 4 of 16
156 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-14 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | −5,000 | -$2.64M | EDGAR |
| 2019-07-11 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$258.2K | EDGAR |
| 2019-06-13 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$171.4K | EDGAR |
| 2019-05-15 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$419.6K | EDGAR |
| 2019-04-11 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$698.4K | EDGAR |
| 2019-03-14 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$811.6K | EDGAR |
| 2019-02-25 | GENOMIC HEALTH INC (GHDX) Delisted | Tax (F) | −4,345 | -$362.1K | EDGAR |
| 2019-02-14 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$897.3K | EDGAR |
| 2019-01-31 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +4,020 | $0 | EDGAR |
| 2019-01-09 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | — | -$689.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.